1·Primary FSGS is an increasing cause of end-stage renal disease.
原发性FSGS是一种正在增长的终末期肾脏疾病的病因。
2·In 2005 Boonsumlit became ill again and was diagnosed with end-stage renal disease.
在2005年，Boonsumlit再次病倒并被诊断为终末期肾病。
3·Objective: To investigate the effect of ACEI combining with ARB on chronic renal disease.
目的：观察长程联合使用ACEI和ARB治疗慢性肾脏疾病的疗效和安全性。
4·Objective To evaluate the QOL of family caregivers of patients with end-stage renal disease.
目的评估终末期肾病患者家庭照料者的生活质量。
5·ObjectiveThe degree of renal tubulointerstitial injury determines the prognosis of renal disease.
目的肾小管间质病变程度是肾脏疾病预后的决定因素。
6·Background Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.
糖尿病肾病是发达国家终末期肾病的主要病因。
7·In ACCORD Lipid, fenofibrate also reduced micro - and macro-albuminuria, markers of diabetic renal disease.
在ACCORD脂质研究基金会，非诺贝特同时降低了微观及宏观尿蛋白量，二者都是胰岛肾病的标志。
8·Methods The animal model of renal disease was induced by unilateral ureteral obstruction (UUO) in CD-1 mice.
方法采用左侧输尿管结扎的方法建立单侧输尿管梗阻（UUO）雄性CD-1 小鼠动物模型。
9·Secondary end points included changes in the level of proteinuria and the rate of progression of renal disease.
次要终点是蛋白尿水平的改变和肾脏疾病的进展程度。
10·High protein intake accelerate the progression of renal disease and low protein intakes have beneficial effects.
高蛋白摄入加速肾病进展，低蛋白摄入对肾脏有益。